Clinical Trials Directory

Trials / Unknown

UnknownNCT04374188

Efficacy of Ciprofloxacin Therapy in Avoidance of Sepsis in Patient Undergoing Percutanous Nephrolithotomy

Efficacy of Ciprofloxacin Therapy in Avoidance of Sepsis in Patient Undergoing Percutanous Nephrolithotomy: A Randomized Controlled Trial

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
200 (estimated)
Sponsor
Diaa Eldin Taha Ramadan Mohamed · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Efficacy of ciprofloxacin therapy in avoidance of sepsis in patient undergoing percutanous nephrolithotomy. A randomized controlled trial.

Detailed description

To figure out the value of oral ciprofloxacin medication in ameliorate the outcome of renal nephrolithiasis extraction via the endoscope as regard the sepsis.

Conditions

Interventions

TypeNameDescription
DRUGCiprofloxacindrug adminstration to ameliorate sepsis incidence
DRUGLevofloxacinlevofloxacin pill

Timeline

Start date
2019-09-01
Primary completion
2021-09-01
Completion
2022-03-01
First posted
2020-05-05
Last updated
2021-03-03

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT04374188. Inclusion in this directory is not an endorsement.

Efficacy of Ciprofloxacin Therapy in Avoidance of Sepsis in Patient Undergoing Percutanous Nephrolithotomy (NCT04374188) · Clinical Trials Directory